Litigation for EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
✉ Email this page to a colleague
US Court Litigation for EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
| Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| 6,043,230 | ⤷ Start Trial | ⤷ Start Trial | 2010-03-05 | 2013-02-20 | 35:271 Patent Infringement | District Court, S.D. New York | None | ⤷ Start Trial |
| 6,043,230 | United States v. Gilead Sciences, Inc. | ⤷ Start Trial | 2019-11-06 | 2024-03-22 | 35:271 Patent Infringement | District Court, D. Delaware | Plaintiff | ⤷ Start Trial |
| 6,043,230 | United States v. Gilead Sciences, Inc. | ⤷ Start Trial | 2019-11-06 | 2024-03-22 | 35:271 Patent Infringement | District Court, D. Delaware | Plaintiff | ⤷ Start Trial |
| 6,043,230 | MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. | ⤷ Start Trial | 2020-01-14 | 2020-01-28 | 15:0002 Antitrust Litigation | District Court, S.D. Florida | Plaintiff | ⤷ Start Trial |
| >Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
